These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 19504647)
1. A cure for peanut allergy? Don't try this at home! Child Health Alert; 2009 Apr; 27():2. PubMed ID: 19504647 [No Abstract] [Full Text] [Related]
2. Peanut allergy. Pansare M; Kamat D Curr Opin Pediatr; 2010 Oct; 22(5):642-6. PubMed ID: 20683330 [TBL] [Abstract][Full Text] [Related]
3. Oral immunotherapy for peanut allergy shows promise but questions remain. Kmietowicz Z BMJ; 2014 Jan; 348():g1265. PubMed ID: 24480396 [No Abstract] [Full Text] [Related]
4. Peanut Allergen Powder (Palforzia) for Peanut Allergy. Erlich D Am Fam Physician; 2022 Jan; 105(1):20-21. PubMed ID: 35029941 [No Abstract] [Full Text] [Related]
5. Successful oral desensitization for systemic peanut allergy. Mansfield L Ann Allergy Asthma Immunol; 2006 Aug; 97(2):266-7. PubMed ID: 16937764 [No Abstract] [Full Text] [Related]
6. Recurrent peanut allergy may not be prevented by continued peanut ingestion. Boyle RJ; Tang ML Int Arch Allergy Immunol; 2008; 147(3):260-2. PubMed ID: 18594158 [TBL] [Abstract][Full Text] [Related]
7. The nut crackers. Swinburne C Nurs Stand; 2009 Aug 26-Sep 1; 23(51):18-20. PubMed ID: 19753772 [TBL] [Abstract][Full Text] [Related]
8. Low dose immunotherapy in very young children to treat peanut allergy. Vickery BP Expert Rev Clin Immunol; 2016 Dec; 12(12):1251-1253. PubMed ID: 27599211 [No Abstract] [Full Text] [Related]
9. Peanut allergy. Hourihane JO Pediatr Clin North Am; 2011 Apr; 58(2):445-58, xi. PubMed ID: 21453812 [TBL] [Abstract][Full Text] [Related]
14. Modified peanut oral immunotherapy protocol safely and effectively induces desensitization. Bird JA; Feldman M; Arneson A; Dougherty I; Brown LS; Burk CM; Kulis M; Burks W; Gill M J Allergy Clin Immunol Pract; 2015; 3(3):433-5.e1-3. PubMed ID: 25609341 [No Abstract] [Full Text] [Related]
15. Looking into the seeds of time: Are home-based OIT programs the shape of things to come for selected patients? Greenhawt M; Hourihane JO Ann Allergy Asthma Immunol; 2018 May; 120(5):453-454. PubMed ID: 29729726 [No Abstract] [Full Text] [Related]
16. Successful oral tolerance induction in severe peanut allergy. Clark AT; Islam S; King Y; Deighton J; Anagnostou K; Ewan PW Allergy; 2009 Aug; 64(8):1218-20. PubMed ID: 19226304 [TBL] [Abstract][Full Text] [Related]
17. Home-based program of maintaining unresponsiveness in children with allergic reactions to larger amounts of peanuts. Arkwright PD; Sharma V; Ewing CI; Hughes SM Ann Allergy Asthma Immunol; 2018 May; 120(5):539-540. PubMed ID: 29126711 [No Abstract] [Full Text] [Related]
18. Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch. Jones SM; Agbotounou WK; Fleischer DM; Burks AW; Pesek RD; Harris MW; Martin L; Thebault C; Ruban C; Benhamou PH J Allergy Clin Immunol; 2016 Apr; 137(4):1258-1261.e10. PubMed ID: 26920463 [No Abstract] [Full Text] [Related]
19. FDA-approved peanut allergy treatment: The first wave is about to crest. Tilles SA; Petroni D Ann Allergy Asthma Immunol; 2018 Aug; 121(2):145-149. PubMed ID: 29909055 [No Abstract] [Full Text] [Related]
20. Author response to Marrs et al., Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal. Anagnostou K; Clark A Br J Dermatol; 2015 Nov; 173(5):1129-30. PubMed ID: 26769643 [No Abstract] [Full Text] [Related] [Next] [New Search]